|
|
Volumn 273, Issue 5273, 1996, Pages 300-301
|
|
Biotech finds a growth industry
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NERVE GROWTH FACTOR;
OSTEOGENIC PROTEIN 1;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
AMYOTROPHIC LATERAL SCLEROSIS;
ANEMIA;
BIOENGINEERING;
DNA DETERMINATION;
DRUG DESIGN;
DRUG MANUFACTURE;
DRUG SYNTHESIS;
FRACTURE;
GENETIC ANALYSIS;
GENETIC ENGINEERING;
NOTE;
PRIORITY JOURNAL;
SKIN CANCER;
STEM CELL;
YOLK SAC;
ANIMALS;
BIOTECHNOLOGY;
CELL DIFFERENTIATION;
DEVELOPMENTAL BIOLOGY;
GENETIC ENGINEERING;
HUMANS;
MOLECULAR BIOLOGY;
NERVE REGENERATION;
PATENTS;
PROTEINS;
|
|
EID: 0030012563
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.273.5273.300 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|